Education
About Us
Working with TipRanks
Follow Us
Roivant Sciences Ltd. (ROIV)
:ROIV
Total Valuation
Roivant Sciences has a market cap or net worth of $7.44B. The enterprise value is $3.85B.
Market Cap$7.44B
Enterprise Value$3.85B
Share Statistics
Roivant Sciences has 713,549,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding713,549,440
Owned by Insiders26.24%
Owned by Institutions0.02%
Financial Efficiency
Roivant Sciences’s return on equity (ROE) is 0.73 and return on invested capital (ROIC) is 60.48%.
Return on Equity (ROE)0.73
Return on Assets (ROA)0.60
Return on Invested Capital (ROIC)60.48%
Return on Capital Employed (ROCE)0.61
Revenue Per Employee137.44K
Profits Per Employee4.66M
Employee Count908
Asset Turnover0.02
Inventory Turnover0.79
Valuation Ratios
The current PE Ratio of Roivant Sciences is 1.88. Roivant Sciences’s PEG ratio is >-0.01.
PE Ratio1.88
PS Ratio78.92
PB Ratio1.37
Price to Fair Value1.37
Price to FCF-10.66
Price to Operating Cash Flow-10.68
PEG Ratio>-0.01
Income Statement
In the last 12 months, Roivant Sciences had revenue of 124.80M and earned 4.35B in profits. Earnings per share was 5.55.
Revenue124.80M
Gross Profit96.83M
Operating Income4.24B
Pretax Income4.25B
Net Income4.35B
EBITDA4.31B
Earnings Per Share (EPS)5.55
Cash Flow
In the last 12 months, operating cash flow was -775.34M and capital expenditures -4.14M, giving a free cash flow of -779.48M billion.
Operating Cash Flow-775.34M
Free Cash Flow-779.48M
Free Cash Flow per Share-1.09
Dividends & Yields
Roivant Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change1.10%
50-Day Moving Average10.37
200-Day Moving Average11.25
Relative Strength Index (RSI)59.34
Average Volume (3m)7.84M
Important Dates
Roivant Sciences upcoming earnings date is Jun 25, 2025, TBA Not Confirmed.
Last Earnings DateFeb 10, 2025
Next Earnings DateJun 25, 2025
Ex-Dividend Date―
Financial Position
Roivant Sciences as a current ratio of 25.24, with Debt / Equity ratio of 1.93%
Current Ratio25.24
Quick Ratio25.10
Debt to Market Cap0.05
Net Debt to EBITDA-1.40
Interest Coverage Ratio121.97
Taxes
In the past 12 months, Roivant Sciences has paid 22.22M in taxes.
Income Tax22.22M
Effective Tax Rate<0.01
Enterprise Valuation
Roivant Sciences EV to EBITDA ratio is 0.49, with an EV/FCF ratio of -2.78.
EV to Sales17.09
EV to EBITDA0.49
EV to Free Cash Flow-2.78
EV to Operating Cash Flow-2.79
Balance Sheet
Roivant Sciences has $5.15B in cash and marketable securities with $100.31M in debt, giving a net cash position of -$5.05B billion.
Cash & Marketable Securities$5.15B
Total Debt$100.31M
Net Cash-$5.05B
Net Cash Per Share-$7.07
Tangible Book Value Per Share$8.06
Margins
Gross margin is 89.03%, with operating margin of 3399.19%, and net profit margin of 3484.86%.
Gross Margin89.03%
Operating Margin3399.19%
Pretax Margin3408.33%
Net Profit Margin3484.86%
EBITDA Margin3453.86%
EBIT Margin3436.20%
Analyst Forecast
The average price target for Roivant Sciences is $44.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$44.25
Price Target Upside312.01% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-20.84%
EPS Growth Forecast-102.48%